Hemostatic material

1 . A hemostatic material, comprising a compound with the structure formula:

wherein N is in a range between about 2 and about 20,000.

2 . The hemostatic material of claim 1 , further comprising a therapeutic agent.

3 . The hemostatic material of claim 2 , wherein the therapeutic agent comprises an agent selected from a list comprising: an anti-inflammatory agent, an anti-infective agent, an anesthetic, a chemotherapy agent.

4 . The hemostatic material of claim 1 , wherein the material is dissolved on the wound surfaces outside human body.

5 . The hemostatic material of claim 1 , wherein the material can be used for hemostasis inside the human body.

6 . The hemostatic material of claim 1 , further comprising a means for affixing the material to the human body.

7 . A process for preparing a hemostatic material, the process comprising:

a) placing sodium hydroxide, sodium carbonate, sodium hypochlorite and water in to a reaction vessel;

b) placing an amount of alcohol into the reaction vessel;

c) placing the raw material to be chemically treated into the reaction vessel; and

d) adding an appropriate amount of alcohol, and an appropriate amount of choloractic acid, into the reaction vessel,

e) adding an appropriate amount of hydrogen peroxide, whereby a hemostatic material is obtained.

8 . The process of claim 7 , wherein the alcohol added is 95% ethyl alcohol pure water and stirring until the ingredients are dissolved.

9 . The process of claim 7 , where in the reaction of step (b) occurs at a temperature between about 25° C. and about 28° C.

10 . The process of claim 7 , wherein the reaction of step (b) is allowed to continue for about 10 hours.

11 . The process of claim 7 , wherein step (c) is performed at a temperature of about 26° C.

12 . The process of claim 7 , wherein step (c) further comprising the steps of:

decreasing the temperature of the solution to about 20° C.;

mixing the solution for a period of about five hours;

cooling the solution to about 5° C.; and

allowing the solution to react at about 5° C. for about one hour.

13 . The process of claim 7 , wherein the alcohol utilized in step (d) is 95% ethyl alcohol.

14 . The process of claim 7 , wherein during step (d) the solution is heated to about 41° C.

15 . The process of claim 7 , wherein step (e) further comprises the steps of:

decreasing the temperature to about 32° C.; and allowing the reaction to continue for a period of about 1.5 hours.

16 . The process of claim 7 further comprising the steps of:

placing the material from the reaction vessel into a separate container;

g) adding an appropriate amount of alcohol;

h) removing excess fluid from the material;

i) adding an appropriate amount of an acid to solution to achieve the desired pH value; and

j) allowing the material to dry.

17 . The process of claim 7 , further comprising: compressing the hemostatic material between a first surface and a second surface; and heating the compressed hemostatic material, whereby a dry hemostatic material is obtained.

18 . A method of controlling bleeding the method comprising: applying a hemostatic material, whereby bleeding is controlled, the hemostatic material comprising a compound with the structure formula:

wherein N is in a range between about 2 and about 20,000.

19 . The method of claim 18 , wherein the hemostatic material further comprises an agent selected from the group consisting of an anti-inflammatory agent, an anti-infective agent, and an anesthetic.

20 . The method of claim 18 , wherein the wound to be treated is selected from a list comprises a tumor bed, a liver wound, a brain wound.